Weissman D E, Stewart C
Department of Medicine, Medical College of Wisconsin, Milwaukee.
J Neurooncol. 1988 Dec;6(4):339-42. doi: 10.1007/BF00177429.
Four drugs with potential anti-peritumoral brain edema activity were studied using the VX2 rabbit brain tumor model. Meclofenamate and indomethacin were tested in an attempt to confirm recent reports of anti-edema activity in non steroidal anti-inflammatory drugs (NSAID's). The 'angiostatic' steroids 17 hydroxyprogesterone and epicortisol were tested because of their lack of glucocorticoid and mineralocorticoid effects and their structural similarity to glucocorticoids. The protein and water component of brain edema were indirectly quantitated. None of the test drugs demonstrated significant anti-edema activity. This work does not confirm reports that NSAID's have anti-edema activity and suggests that there may be no correlation between 'angiostatic' and anti-edema activity in certain steroid compounds.
使用VX2兔脑肿瘤模型对四种具有潜在抗瘤周脑水肿活性的药物进行了研究。测试了甲氯芬那酸和吲哚美辛,以试图证实近期关于非甾体抗炎药(NSAID)抗水肿活性的报道。测试了“血管生成抑制性”类固醇17-羟孕酮和表皮质醇,因其缺乏糖皮质激素和盐皮质激素作用,且与糖皮质激素结构相似。间接定量了脑水肿的蛋白质和水分成分。所测试的药物均未显示出显著的抗水肿活性。这项研究并未证实NSAID具有抗水肿活性的报道,并表明某些类固醇化合物的“血管生成抑制性”与抗水肿活性之间可能不存在相关性。